Pediatric cancer

A three-year-old boy with metastatic liver cancer had already endured chemotherapy, major surgery and multiple attempts to remove tumors when doctors turned to an experimental immune-cell therapy. His cancer had returned despite aggressive treatment, leaving researchers with a difficult case and few conventional options. Then came an extraordinary result. After two outpatient infusions of genetically …